Dihydroartemisinin- piperaquine dispersible
Product development
-
Patient confirmatory
DHA-PQP dispersible
Alfasigma
Asexual blood stages
Paediatric formulation
No progress report in last two years
3-day cure, artemisinin-based combination therapies (TPP-1)
Product vision |
|
Dosing |
|
Efficacy |
|
Key features |
|
Challenges |
|
Status |
|
Next milestone | |
Project Director |
|